Competitor Analysis available at PipelineReview Store

Newsletters

Weekly newsletter focused on antibodies, proteins & peptides, gene therapy, RNA and cell therapy, vaccines, biogenerics and related business. It contains brief abstracts of preclinical & clinical studies, regulatory updates and company news of the previous week, but for biologics only. Subscribe Now

Consultancy

Need consultancy on this topic? La Merie SL provides consultancy services to all clients who wish a fully personal, individual, strictly confidential and exclusive collaboration on a specific subject.

Biogenerics Market

 

Biogenerics & Therapeutic Proteins Overview

No.

Class of Products

2006 sales (US$ bln.)

Selected Branded Products

1

Erythropoietins

11.94

Aranesp, Procrit Eprex, Epogen, Neo-Recormon, ESPO

2

Major cancer antibodies

10.62

Rituxan/MabThera, Herceptin, Avastin, Erbitux, Vectibix

3

Anti-TNF antibodies

10.28

Enbrel, Remicade, Humira

4

Insulin and insulin analogs

8.97

Humalog, Humulin, Lantus, Levemir, Novorapid, Actrapid, Novolin

5

Rec. coagulation factors

4.71

Novoseven, Kogenate, Helixate, Refacto, Advate, Recombinate, Benefix

6

Interferon beta

4.40

Avonex, Rebif, Betaferon / Betaseron

7

G-CSF

4.36

Neulasta, Neupogen, Neutrogin, GRAN

8

Human growth hormone

2.47

Genotropin, Norditropin, Humatrope, Nutropin, Saizen, Serostim

9

Interferon alpha

2.26

Pegasys, Peg-Intron, Intron A

10

Enzyme Replacement

1.71

Cerezyme, Fabrazyme, Aldurazyme, Myozyme, Replagal, Naglazyme, Elaprase

11

Antiviral antibody

1.1

Synagis

12

Follicel stimulating hormones

1.04

Gonal-f, Puregon

 

Total:

63.83